WebOTLK Swing-trade (and potential long-term growth) idea OTLK (Outlook Therapeutics, Inc.) is expected to commercialize the first and only FDA-approved ophthalmic formulation of bevacizumab-vikg for use in treating … WebGet the latest Outlook Therapeutics, Inc. (OTLK) stock news and headlines to help you in your trading and investing decisions.
Archive
WebFind the latest Outlook Therapeutics, Inc. (OTLK) stock discussion in Yahoo Finance's forum. Share your opinion and gain insight from other stock traders and investors. WebApr 6, 2024 · Stock Price Forecast. According to 12 stock analysts, the average 12-month stock price forecast for OTLK stock is $ 6.97 , which predicts an increase of 576.70%. The lowest target is $ 4.04 and the highest is $ 10.5. On … gateway vimar arkè
OTLK Outlook Therapeutics Inc. Stock Overview (U.S.: Nasdaq ...
WebPrice target. 6.88R USD +5.79 +530.73%. The 6 analysts offering 1 year price forecasts for Outlook Therapeutics, Inc. have a max estimate of 10.00 and a min estimate of 4.00. WebWith Outlook Therapeutics stock trading at $1.00 per share, the total value of Outlook Therapeutics stock (market capitalization) is $256.67M. Outlook Therapeutics stock was originally listed at a price of $34.16 in Jun 14, 2016. If you had invested in Outlook Therapeutics stock at $34.16, your return over the last 6 years would have been -97. ... WebApr 8, 2024 · Outlook Therapeutics Inc. (NASDAQ:OTLK) price on Thursday, April 06, rose 0.98% above its previous day’s close as an upside momentum from buyers pushed the stock’s value to $1.03. A look at the stock’s price movement, the close in the last trading session was $1.02, moving within a range at $1.00 and $1.04. The beta value (5-Year … dawn seaworld trainer death video